Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Cheeky's Board! Message Board

$ARWR Recent News Despite skepticism, market t

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 94263
Posted On: 04/25/2014 11:07:37 AM
Avatar
Posted By: Stock_Tracker
$ARWR Recent News

Despite skepticism, market technicals remain bullish 12:53 p.m. March 11, 2014 - Michael Ashbaugh
Despite skepticism, market technicals remain bullish 12:40 p.m. March 11, 2014 - Michael Ashbaugh
U.S. benchmarks rattle the cage on major resistance 1:16 p.m. Feb. 7, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:06 p.m. Jan. 28, 2014 - Michael Ashbaugh
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
A 6-pack of hedge fund moves to take note of 12:08 p.m. Oct. 21, 2013 - Insider Monkey
Six stocks poised to move higher 3:23 p.m. Oct. 2, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:00 p.m. Sept. 26, 2013 - The Trading Deck
Arrowhead reports positive data on hep B drug 2:10 p.m. Feb. 26, 2013 - MarketWatch.com
Six companies unveil share, unit offerings 8:45 a.m. Dec. 7, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:12 p.m. Aug. 13, 2012 - MarketWatch

First Week Of ARWR December 20th Options Trading 10:58 a.m. April 23, 2014 - TheStreet.com
Stock To Watch: Arrowhead Research Corporation (ARWR) In Perilous Reversal 9:52 a.m. April 17, 2014 - TheStreet.com
Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock 9:47 a.m. April 16, 2014 - TheStreet.com
Mid-Afternoon Market Update: Markets Trade in Highly Volatile Session as Talk of a Pull-Back is Widespread 2:59 p.m. April 15, 2014 - benzinga.com
Why Arrowhead Research (ARWR) Stock is Down Today 3:00 p.m. April 14, 2014 - TheStreet.com
Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock 10:15 a.m. April 7, 2014 - TheStreet.com
Stock To Watch: Arrowhead Research Corporation (ARWR) In Perilous Reversal 9:47 a.m. April 2, 2014 - TheStreet.com
Why Arrowhead Research (ARWR) Stock Is Up Today 11:24 a.m. April 1, 2014 - TheStreet.com
Interesting ARWR Put And Call Options For May 17th 11:52 a.m. March 26, 2014 - TheStreet.com
Trade of the Day: Teva Pharmaceuticals (TEVA) and Mylan (MYL) 5:04 a.m. March 26, 2014 - InvestorPlace.com
Deutsche Bank Remains Positive on Arrowhead Research Despite Weakness 7:03 a.m. March 25, 2014 - benzinga.com
Deutsche Bank Defends Arrowhead Amid ~16% Decline, Reiterates Buy 5:10 p.m. March 24, 2014 - benzinga.com
Hot Stocks for Tuesday, March 18 11:30 a.m. March 19, 2014 - WallStreetSectorSelector
Perilous Reversal Watch: Arrowhead Research Corporation (ARWR) 9:58 a.m. March 11, 2014 - TheStreet.com
3 Biotech Winners on Wednesday: Arrowhead, Osiris, Tekmira 2:49 p.m. March 5, 2014 - Wall St. Cheat Sheet
Why Arrowhead Research (ARWR) His a Five-Year High Today 2:31 p.m. March 5, 2014 - TheStreet.com
Today's Top Performers In Health Care 12:02 p.m. March 5, 2014 - TheStreet.com
Arrowhead Surges As Analysts Laud Hepatitis B Drug 10:14 a.m. March 5, 2014 - Investors Business Daily
Benzinga's Volume Movers 9:24 a.m. March 5, 2014 - benzinga.com
Morning Movers for Mar. 5, 2014: FCEL, ARWR, SWHC, CPST Moving Higher 8:52 a.m. March 5, 2014 - benzinga.com


Top Gainers on the Move -- Research on Arrowhead Research, Endocyte, Ambac Financial, and ZIOPHARM Oncology 12:40 p.m. April 23, 2014 - PR Newswire - PRF
Patient Enrollment, Acquisitions, FDA Reviews, and Results of Earnings and Clinical Trials - Analyst Notes on Arrowhead, Providence, Durata, Orthofix, and Idera 8:00 a.m. April 4, 2014 - PR Newswire - PRF
Top Gainers under the Scanner -- Research on Trina Solar, JA Solar, Arrowhead Research, and King Digital Entertainment 9:59 a.m. April 2, 2014 - PR Newswire - PRF
Arrowhead Completes Enrollment of First Cohort in Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 7:30 a.m. April 1, 2014 - BusinessWire - BZX
Arrowhead Begins Dosing in Phase 2a Trial of RNAi Therapeutic ARC-520 in Chronic Hepatitis B Patients 7:30 a.m. March 24, 2014 - BusinessWire - BZX
Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ANI, OraSure, Rigel, and Foundation Medicine 12:30 p.m. March 10, 2014 - PR Newswire - PRF
Arrowhead to Present at Barclays Global Healthcare Conference 7:30 a.m. March 10, 2014 - BusinessWire - BZX
Pre-Market Top Gainers Analysis: Smith & Wesson Holding, DryShips, Arrowhead Research and ZBB Energy 12:38 p.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Autodesk, Pfizer, Arrowhead Research, Discover Financial, and Vodafone Released By InvestorsObserver 9:31 a.m. March 6, 2014 - PR Newswire - PRF
Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 7:30 a.m. March 3, 2014 - BusinessWire - BZX
Arrowhead Closes Underwritten Offering with Gross Proceeds of $120 Million 8:59 a.m. Feb. 24, 2014 - BusinessWire - BZX
Arrowhead Listing Upgraded to NASDAQ Global Select Market 7:30 a.m. Feb. 21, 2014 - BusinessWire - BZX
Arrowhead to Present at RBC Capital Markets' Global Healthcare Conference 4:01 p.m. Feb. 20, 2014 - BusinessWire - BZX
Judge Approves Lehman Brothers $767M Settlement; Arrowhead Research Hits New 52-week High 12:30 a.m. Feb. 20, 2014 - ACCESSWIRE
Arrowhead Announces Pricing of Underwritten Offering of Common Stock 9:05 a.m. Feb. 19, 2014 - BusinessWire - BZX
Arrowhead Announces Proposed Underwritten Offering of Common Stock 4:14 p.m. Feb. 18, 2014 - BusinessWire - BZX
Arrowhead Reports Fiscal 2014 First Quarter Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Arrowhead to Participate in Panel Discussions at 16th Annual BIO CEO & Investor Conference 7:30 a.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For First Solar, Arrowhead Research, Genuine Parts, Royal Dutch Shell, and Shire Released By InvestorsObserver 9:31 a.m. Jan. 29, 2014 - PR Newswire - PRF
Arrowhead to Report Fiscal 2014 First Quarter Financial Results 4:10 p.m. Jan. 28, 2014 - BusinessWire - BZX



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us